TIMOLOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Timolol, and when can generic versions of Timolol launch?
Timolol is a drug marketed by Epic Pharma Llc, Alembic, Dr Reddys, Eugia Pharma, Gland Pharma Ltd, Sandoz, Akorn, Amring Pharms, Apotex, Apotex Inc, Bausch And Lomb, Fdc Ltd, Fougera, Hikma, Ingenus Pharms Llc, Mankind Pharma, Micro Labs, Pacific Pharma, Sentiss Pharma, Ani Pharms, Chartwell Rx, Mylan, Quantum Pharmics, Rising, Teva, Usl Pharma, and Watson Labs. and is included in fifty NDAs.
The generic ingredient in TIMOLOL is timolol maleate. There are fifteen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the timolol maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Timolol
A generic version of TIMOLOL was approved as timolol maleate by MYLAN on June 8th, 1990.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TIMOLOL?
- What are the global sales for TIMOLOL?
- What is Average Wholesale Price for TIMOLOL?
Summary for TIMOLOL
US Patents: | 0 |
Applicants: | 27 |
NDAs: | 50 |
Raw Ingredient (Bulk) Api Vendors: | 33 |
Clinical Trials: | 238 |
Patent Applications: | 7,822 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for TIMOLOL |
Drug Sales Revenues: | Drug sales revenues for TIMOLOL |
DailyMed Link: | TIMOLOL at DailyMed |
![TIMOLOL drug patent expirations Drug patent expirations by year for TIMOLOL](/p/graph/s/t/TIMOLOL-patent-expirations.png)
![Drug Prices for TIMOLOL](/p/graph/drug-price/TIMOLOL.png)
![Drug Sales Revenue Trends for TIMOLOL](/p/graph/drug-sales-revenues/TIMOLOL.png)
Recent Clinical Trials for TIMOLOL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Laboratorios Poen | Phase 4 |
The University of Texas Health Science Center, Houston | Phase 4 |
Taipei Medical University WanFang Hospital | N/A |
Medical Subject Heading (MeSH) Categories for TIMOLOL
Anatomical Therapeutic Chemical (ATC) Classes for TIMOLOL
US Patents and Regulatory Information for TIMOLOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ani Pharms | TIMOLOL MALEATE | timolol maleate | TABLET;ORAL | 072917-001 | Jul 31, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Mankind Pharma | TIMOLOL MALEATE | timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 078771-002 | Sep 28, 2009 | AT1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Mylan | TIMOLOL MALEATE | timolol maleate | TABLET;ORAL | 072668-001 | Jun 8, 1990 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Usl Pharma | TIMOLOL MALEATE | timolol maleate | TABLET;ORAL | 072002-001 | Apr 11, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Chartwell Rx | TIMOLOL MALEATE | timolol maleate | TABLET;ORAL | 072551-001 | Apr 13, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Quantum Pharmics | TIMOLOL MALEATE | timolol maleate | TABLET;ORAL | 072466-001 | May 19, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |